prikaz prve stranice dokumenta Immunotherapy of urinary bladder carcinoma
  Download
PDF 151.39 KB
Scientific paper - Review paper
Immunotherapy of urinary bladder carcinoma
Libri Oncologici : Croatian Journal of Oncology, 45 (2017), 2-3; 52-54. urn:nbn:hr:184:579154
Zahirović, Dag; Pavlović Ružić, Ira; Belac-Lovasić, Ingrid

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Zahirović, D., Pavlović Ružić, I. & Belac Lovasić, I. (2017). Immunotherapy of urinary bladder carcinoma. Libri Oncologici : Croatian Journal of Oncology, 45. (2-3), 52-54. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:579154

Zahirović, Dag, et al. "Immunotherapy of urinary bladder carcinoma." Libri Oncologici : Croatian Journal of Oncology, vol. 45, no. 2-3, 2017, pp. 52-54. https://urn.nsk.hr/urn:nbn:hr:184:579154

Zahirović, Dag, Ira Pavlović Ružić and Ingrid Belac Lovasić. "Immunotherapy of urinary bladder carcinoma." Libri Oncologici : Croatian Journal of Oncology 45, no. 2-3 (2017): 52-54. https://urn.nsk.hr/urn:nbn:hr:184:579154

Zahirović, D., Pavlović Ružić, I. and Belac Lovasić, I. (2017) 'Immunotherapy of urinary bladder carcinoma', Libri Oncologici : Croatian Journal of Oncology, 45(2-3), pp. 52-54. Available at: https://urn.nsk.hr/urn:nbn:hr:184:579154 (Accessed 22 November 2024)

Zahirović D, Pavlović Ružić I, Belac Lovasić I. Immunotherapy of urinary bladder carcinoma. Libri Oncologici : Croatian Journal of Oncology [Internet]. 2017 December 21 [cited 2024 November 22];45(2-3):52-54. Available at: https://urn.nsk.hr/urn:nbn:hr:184:579154

D. Zahirović, I. Pavlović Ružić and I. Belac Lovasić, "Immunotherapy of urinary bladder carcinoma", Libri Oncologici : Croatian Journal of Oncology, vol. 45, no. 2-3, pp. 52-54, December 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:579154. [Accessed: 22 November 2024]

Metadata
Title (english)Immunotherapy of urinary bladder carcinoma
Title (croatian)Imunoterapija karcinoma mokraćnog mjehura
AuthorDag Zahirović
AuthorIra Pavlović Ružić
AuthorIngrid Belac-Lovasić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Oncology and Radiotherapy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Oncology
Abstract (english)
Urothelial urinary bladder carcinoma represents 9th most common malignancy in the world. This disease is held responsable for more than 165000 deaths throughout the world. In the past 30 years there were no major advances in treatment of this tumor. Chemotherapy regimens used for treatment are based on platinum compounds. In a recent time a series of immune system modulating drugs have been developed. This drugs have achieved excellent results in the treatment of urinary bladder carcinoma.
Abstract (croatian)
Karcinom mokraćnog mjehura je deveti najčešći maligni tumor u svijetu. Bolest je uzrok više od 165.000 smrtnih slučajeva. U posljednjih 30 godina nije bilo većih pomaka u mogućnostima liječenja ovoga tumora. Kemoterapijski protokoli za liječenje uznapredovale ili metastatske bolesti mokraćnog mjehura bazirani su uglavnom na spojevima platine. U posljednje vrijeme razvijen je niz novih lijekova koji moduliraju imunološki odgovor organizma na tumorske stanice i time omogućavaju uspješno liječenje karcinoma mokraćnog mjehura.
Keywords (english)
Keywords (croatian)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleLibri Oncologici : Croatian Journal of Oncology
Numberingvol. 45, no. 2-3, pp. 52-54
p-ISSN0300-8142
e-ISSN2584-3826
URN:NBNurn:nbn:hr:184:579154
Publication2017-12-21
Document URLhttp://hrcak.srce.hr/192130
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2018-01-10 18:39:36